Literature DB >> 23075016

Truncated robust distance for clinical laboratory safety data monitoring and assessment.

Xiwu Lin1, Daniel Parks, Lei Zhu, Lloyd Curtis, Helen Steel, Andrew Rut, Vincent Mooser, Lon Cardon, Alan Menius, Kwan Lee.   

Abstract

Laboratory safety data are routinely collected in clinical studies for safety monitoring and assessment. We have developed a truncated robust multivariate outlier detection method for identifying subjects with clinically relevant abnormal laboratory measurements. The proposed method can be applied to historical clinical data to establish a multivariate decision boundary that can then be used for future clinical trial laboratory safety data monitoring and assessment. Simulations demonstrate that the proposed method has the ability to detect relevant outliers while automatically excluding irrelevant outliers. Two examples from actual clinical studies are used to illustrate the use of this method for identifying clinically relevant outliers.

Mesh:

Substances:

Year:  2012        PMID: 23075016     DOI: 10.1080/10543406.2011.580483

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations.

Authors:  Xiwu Lin; Daniel Parks; Jeffery Painter; Christine M Hunt; Heide A Stirnadel-Farrant; Jie Cheng; Alan Menius; Kwan Lee
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

Review 2.  Methodology to assess clinical liver safety data.

Authors:  Michael Merz; Kwan R Lee; Gerd A Kullak-Ublick; Andreas Brueckner; Paul B Watkins
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 3.  Next-Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.

Authors:  Sharin E Roth; Mark I Avigan; David Bourdet; David Brott; Rachel Church; Ajit Dash; Douglas Keller; Philip Sherratt; Paul B Watkins; Lucas Westcott-Baker; Silvia Lentini; Michael Merz; Lila Ramaiah; Shashi K Ramaiah; Ann Marie Stanley; John Marcinak
Journal:  Clin Pharmacol Ther       Date:  2019-09-14       Impact factor: 6.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.